Substance Use Disorder Prior Authorization Checklist
Use a substance use disorder prior authorization checklist for payer policy, level and setting, qualified evidence, 42 CFR Part 2, medications, submission, decision scope, concurrent review, transitions, and appeals.
On this page: Direct answer
Direct answer
Substance use disorder prior authorization checklist: what operators need to know
Use a substance use disorder prior authorization checklist for payer policy, level and setting, qualified evidence, 42 CFR Part 2, medications, submission, decision scope, concurrent review, transitions, and appeals. Verify the exact payer, product, authorization entity, service, level, setting, network, and policy version.
A substance use disorder prior authorization checklist should connect the exact payer, plan, benefit, network, service, level, setting, provider, dates, and request type to the current policy and qualified clinical record. It should also govern confidentiality, submission proof, written decision scope, concurrent review, transitions, medications, denials, and appeals.
No checklist can determine the appropriate treatment or guarantee authorization. SUD care is individualized, payer requirements vary, and 42 CFR Part 2 may apply to records from covered programs. Use current payer sources, qualified clinical judgment, privacy and legal review, and immediate clinical or crisis pathways when needed; do not delay urgent care to complete administrative work.
Key takeaways
The short version
- Verify the exact payer, product, authorization entity, service, level, setting, network, and policy version.
- Map each requirement to dated evidence authored or approved by the qualified person.
- Apply Part 2, HIPAA, state, consent, and minimum-necessary rules to the actual disclosure context.
- Reconcile approved scope against requested, planned, and delivered care.
- Work backward from concurrent-review, expiration, peer-review, and appeal deadlines.
Take the template with you
Free to copy · no email required
Adapt this administrative structure to the current payer policy, qualified clinical workflow, and applicable confidentiality requirements.
# Substance use disorder prior authorization checklist ## Request and coverage - Member / payer / plan / benefit / carve-out / network: - Service / level / setting / provider / facility / dates / units: - Policy / version / form / route / deadline: ## Evidence - Requirement / source / qualified author / date / packet location: - Missing / conflicting / stale / N-A / clarification: ## Confidentiality and decision - Part 2 / HIPAA / state / purpose / recipient / authority review: - Submission / receipt / reference / clock: - Requested versus approved scope / conditions / expiration: - Pend or denial / notice / rights / deadline / owner:
1. Substance use disorder prior authorization checklist
| Domain | Fields to verify | Control |
|---|---|---|
| Coverage | Member, payer, product, benefit, carve-out, network, entity, service, provider, facility, and location | Source, trace, date, context, and uncertainty |
| Request | Initial, concurrent, extension, transition, medication, level, setting, dates, units or days, and urgency | Current policy, version, form, channel, and clock |
| Clinical record | Assessment, diagnosis context, severity, function, risks, co-occurring needs, history, response, plan, and transition as required | Qualified author, source, date, version, and no unsupported inference |
| Medication | Exact medication or service pathway, prescriber, indication context, history, monitoring, and payer-required fields | Current labeling and payer source; clinician approval |
| Confidentiality | Part 2 status, purpose, recipient, authority, consent or TPO context, minimum necessary, state rules, and redisclosure | Privacy or legal analysis reflected in workflow |
| Decision | Approved, partial, pended, denied, dates, level, setting, provider, site, units, conditions, reason, and rights | Written response reconciled by an owner |
2. Build a requirement-to-evidence packet
- 01
Retrieve the current rule
Confirm payer, plan, benefit, entity, jurisdiction, service, level, setting, network, request type, policy, version, forms, route, and deadlines.
- 02
Create the matrix
Connect each requirement to the authoritative source, author, date, reviewer, status, and packet location.
- 03
Expose gaps
Mark present, missing, conflicting, stale, not applicable, pending qualified review, or payer clarification; never turn absence into a generated fact.
- 04
Review disclosure
Validate recipient, purpose, authority, Part 2 and HIPAA context, minimum necessary, secure route, and any required disclosure record.
- 05
Approve and submit
Verify identity, request, sources, authorship, consistency, version, attachments, recipient, channel, and submission authority before preserving receipt.
3. Control concurrent review and level transitions
- Build the next review from the payer deadline, internal clinical-review time, evidence availability, weekends, holidays, and fallback
- Track requested, approved, scheduled, delivered, canceled, transferred, discharged, noncovered, and remaining service separately
- Use qualified clinicians to author current progress, response, risks, function, plan, medication context, and requested level
- Treat every level, setting, facility, provider, network, product, or service change as a potential new coverage question
- Give payer questions an owner, exact item, clinical author, due time, response evidence, and confirmation
- Do not let an administrative deadline override immediate clinical or crisis escalation or professional judgment
4. Reconcile the decision and communicate limits
| Outcome | Reconcile | Next action |
|---|---|---|
| Approved | Service, level, setting, provider, facility, location, dates, units, conditions, and next review | Compare schedule and communicate without promising payment |
| Partial | Requested versus approved fields and uncovered gap | Clarify or route review and appeal rights; clinical changes remain clinician-led |
| Pended | Exact item, author, recipient, due time, payer clock, and access risk | Respond, confirm receipt, and keep escalation visible |
| Denied | Reason, policy, evidence, notice, rights, peer review, appeal, and deadline | Separate clinical response, correction, benefit, and parity review |
| Ambiguous | Failed channel, status conflict, missing response, or unclear scope | Escalate, use fallback, preserve attempts, and prevent assumptions |
5. Prepare review or appeal from the exact adverse action
- Index the request, source evidence, authorship, submission proof, communications, decision, notice, policy, and deadlines
- Classify benefit, network, authorization, administrative, missing-information, medical-necessity, level, duration, medication, or other reason
- Have qualified clinicians address clinical criteria and patient-specific evidence in their own reviewed judgment
- Review applicable parity, plan, state, federal, urgent, external-review, and representation routes with qualified owners
- Confirm destination, signature, delivery, receipt, reference, follow-up, outcome, corrected scope, and communication
Common questions
Answers before you build.
Does substance use disorder treatment require prior authorization?+
It depends on the payer, plan, benefit, service, medication, level, setting, provider, facility, network, jurisdiction, and date. Verify the current policy and do not infer requirements from a different plan or level.
What records are needed for SUD prior authorization?+
Use the current payer’s requirements. A request may call for administrative fields and qualified clinical evidence about assessment, diagnosis context, severity, risks, function, history, response, plan, level, setting, medication, or transition.
Does 42 CFR Part 2 apply to every addiction-treatment record?+
No. Applicability depends on the program, record, holder, disclosure, and other facts. The 2024 final rule aligned several provisions with HIPAA, with compliance required February 16, 2026, but Part 2 remains distinct. Obtain qualified review.
Can a prior authorization checklist choose a level of care?+
No. The checklist organizes administrative requirements and source evidence. Qualified clinicians make assessment and treatment decisions using professional judgment and applicable clinical standards.
Practical closeout
Use this operator checklist.
- Verify the exact payer, product, authorization entity, service, level, setting, network, and policy version.
- Map each requirement to dated evidence authored or approved by the qualified person.
- Apply Part 2, HIPAA, state, consent, and minimum-necessary rules to the actual disclosure context.
- Reconcile approved scope against requested, planned, and delivered care.
- Work backward from concurrent-review, expiration, peer-review, and appeal deadlines.
Continue through the cluster
Verified customer case studies are added only with customer permission and supporting evidence; none is implied by these operational examples.
Sources & methodology
Trace the operational claims.
Marsa Health Editorial reviewed the primary and research sources below on July 22, 2026. We translate them into workflow controls, distinguish proposals from final rules, and flag where plan, program, state, contract, or clinical requirements vary.
- 01Substance Use Disorder Treatment Substance Abuse and Mental Health Services AdministrationCurrent federal treatment and referral resources, including evidence-based care, low-barrier models, medications, SBIRT, and treatment locators. It does not define payer-specific authorization criteria.Accessed or rechecked July 22, 2026
- 02Understanding Confidentiality of Substance Use Disorder Patient Records or Part 2 U.S. Department of Health and Human ServicesCurrent OCR overview of Part 2 scope, the 2024 final rule, the February 16, 2026 compliance date, enforcement, breach reporting, and model notices.Accessed or rechecked July 22, 2026
- 03Fact Sheet: 42 CFR Part 2 Final Rule U.S. Department of Health and Human ServicesUpdated January 2026 overview of SUD patient-record confidentiality changes and the February 16, 2026 compliance date.Accessed or rechecked July 22, 2026
- 04Minimum Necessary Requirement U.S. Department of Health and Human ServicesHIPAA guidance on limiting uses, disclosures, and requests for protected health information when the standard applies.Accessed or rechecked July 22, 2026
- 05Medicare Coverage Database Centers for Medicare & Medicaid ServicesOfficial search for current national and local Medicare coverage documents. Users must select the relevant jurisdiction, effective version, service, and linked billing article.Accessed or rechecked July 22, 2026
- 06CMS Interoperability and Prior Authorization Final Rule CMS-0057-F Centers for Medicare & Medicaid ServicesCurrent implementation dates, decision timeframes, denial-reason requirements, metrics, and API provisions for impacted payers.Accessed or rechecked July 22, 2026
- 07How to appeal an insurance company decision Centers for Medicare & Medicaid ServicesFederal overview of internal appeals, external review, notices, and general appeal timing. Plan and state rules can differ.Accessed or rechecked July 22, 2026
- 08Medicaid and CHIP Parity Compliance Toolkit Medicaid.govOfficial framework for identifying and analyzing nonquantitative treatment limitations, including prior authorization, in Medicaid and CHIP contexts.Accessed or rechecked July 22, 2026
Organizational author. Editorial review covers source accuracy, search intent, workflow boundaries, and human-oversight requirements. This material is educational and does not provide clinical, legal, coding, or coverage advice.
No named clinical or legal expert reviewer is attributed to this version. Marsa Health does not invent reviewer credentials.
Read our editorial methodRevision history
What changed and when
July 22, 2026
Initial publication, source review, and operational editing.